The Government of India, through the National Pharmaceutical Pricing Authority (NPPA), has capped the trade margin at 30% on 137 anti-cancer medicines. The aim is to make cancer treatment more affordable for patients.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
Explore diverse prescription solutions in our A-Z pharmaceutical product catalog.
View by-
